Visit In the Pipeline

Sharing the Enlightenment

Posted on July 11, 2008

Here's an interesting idea: Merck, Lilly, and Pfizer are bankrolling a startup company to look for new technologies for drug development. Enlight Biosciences will focus on the biggest bottlenecks and risk points in the process, including new imaging techniques for preclinical and clinical evaluation of drug candidates, predictive toxicology and pharmacokinetics, clinical biomarkers, new models of disease, delivery methods for protein- and nucleic acid-based therapies, and so on.It's safe to say that if any real advances are made in any of these, the venture will have to be classed as a success...

Original article link


disease , protein , startup , vc